In8 Bio, Inc. financial data

Symbol
INAB on Nasdaq
Location
Empire State Building, 350 5 Th Avenue, Suite 5330, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 524 %
Debt-to-equity 35.5 %
Return On Equity -146 % +26.2%
Return On Assets -107 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.63M shares -93.6%
Common Stock, Shares, Outstanding 4.59M shares -90.2%
Entity Public Float 29M USD +27.8%
Common Stock, Value, Issued 10K USD +100%
Weighted Average Number of Shares Outstanding, Basic 4.54M shares +188%
Weighted Average Number of Shares Outstanding, Diluted 4.54M shares +188%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 11.2M USD -37.6%
General and Administrative Expense 9.9M USD -24.4%
Operating Income (Loss) -20.7M USD +35.2%
Net Income (Loss) Attributable to Parent -20.7M USD +35.2%
Earnings Per Share, Basic 7 USD/shares +81.1%
Earnings Per Share, Diluted 7 USD/shares +81.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 346K USD +95.5%
Assets, Current 11.8M USD +75.6%
Property, Plant and Equipment, Net 2.1M USD -31.7%
Operating Lease, Right-of-Use Asset 2.04M USD -50.5%
Other Assets, Noncurrent 169K USD -47.8%
Assets 16.8M USD +5.02%
Accounts Payable, Current 204K USD -82.1%
Accrued Liabilities, Current 418K USD -45.6%
Liabilities, Current 1.7M USD -53.2%
Operating Lease, Liability, Noncurrent 1.81M USD -45.8%
Liabilities 3.58M USD -51.5%
Retained Earnings (Accumulated Deficit) -136M USD -17.9%
Stockholders' Equity Attributable to Parent 13.2M USD +53.6%
Liabilities and Equity 16.8M USD +5.02%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.12M USD +60.6%
Net Cash Provided by (Used in) Financing Activities 3.89M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 490M shares 0%
Common Stock, Shares, Issued 4.59M shares -90.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 771K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11M USD +157%
Deferred Tax Assets, Valuation Allowance 25.2M USD +28.3%
Deferred Tax Assets, Gross 26.2M USD +27%
Operating Lease, Liability 2.55M USD -40.2%
Depreciation 993K USD +3.65%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 3.14M USD -42%
Operating Lease, Liability, Current 738K USD -19.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.02M USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.22M USD -13.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure +15.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 587K USD -48.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 680K USD -44.4%
Deferred Tax Assets, Operating Loss Carryforwards 2.7M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 66K USD -92.6%
Additional Paid in Capital 149M USD +20.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 19.6M USD +41.3%
Share-based Payment Arrangement, Expense 3.3M USD -39.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%